Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis.
Affiliation
Sandwell and West Birmingham NHS Trust; Queen Elizabeth Hospital; University of HullPublication date
2021-07-16Subject
Rheumatology
Metadata
Show full item recordAbstract
Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associatedCitation
Goel R, Morgan M, Chanouzas D, Caplan J, Logan S, Harper L. Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis. Rheumatol Adv Pract. 2021 Jul 16;5(2):rkab039. doi: 10.1093/rap/rkab039.Type
ArticlePMID
34632259Publisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/rap/rkab039